Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Appendix D Respondents to Input Request The following individuals responded to a request from the chairman to provide a position statement from themselves or for their respective organization on the allocation of health research resources. The affiliation noted in the following list reflects their official capacity at the time of the response. DAVID BALTIMORE, Director, Whitehead Institute MAURICE Q. BECTEL, President, Pharmaceutical Manufacturers Association Foundation, Inc. ROSEMARY H. BRUNER, Administrative Director, The Hoffman-La Roche Foundation PEDRO CUATRECASAS, Senior Vice President of Research and Development, Glaxo Research Laboratories, Glaxo, Inc. JEAN FITZGERALD DUBOIS, Program Officer, W.M. Keck Foundation L.N FISK, Associate Administrator for Space Science and Applications, National Aeronautics and Space Administration TIMOTHY S. GEE, Attending Physician, Hematology/Lymphoma Service, Memorial Sloan-Kettering Cancer Center RICHARD J. GLASSOCK, President, National Kidney Foundation, Inc. BERNADINE MEALY, President, American Heart Association ROBERT W. KRAUSS, Executive Director, Federation of American Societies for Experimental Biology RONALD KUNTZMAN, Vice President of Research and Development, Hof~nan-La Roche, Inc. 242
RESPONDENTS TO INPUT REQUEST 243 KATHERINE McCARTER, President, Coalition for Health Funding LYNN MORRISON, Director for Public Policy, American Federation for Clinical Research GERALD J. MOSSINGHOFF, President, Pharmaceutical Manufacturers Association JOHN PRAM, President, Association of Independent Research Institutes at Whitehead Institute RICHARD S. ROSS, Vice President for Medicine, Dean of the Medical Faculty, The Johns Hopkins University School of Medicine EDWARD M. SCOLNICK, President of Research, Merck Sharp & Dohme Research Laboratories, Division of Merck & Co., Inc. RICHARD S. SHARPE, Program Director, The John ~ Hartford Foundation, Inc. SOLOMON H. SNYDER, Distinguished Service Professor of Neuroscience, Pharmacology and Psychiatry, Department of Neuroscience, The Johns Hopkins University EDWIN C. WHITEHEAD, Whitehead Associates DANIEL H. WINSHIP, Associate Deputy Chief Medical Director, Department of Medicine and Surgery, Veterans Administration
